Related news for:   cancer

Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for Blood Cancer.

04

Sep

Mater Research CEO appointed to new National Blood Cancer Taskforce

Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with follicular lymphoma.

29

Aug

Immune infiltration 'promising tool' to improve outcomes for follicular lymphoma

More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model thanks to Mater Research.

18

Jul

New score to help navigate improved treatment for follicular lymphoma patients

Mater Research—University of Queensland (MRI—UQ) Acting Director Professor Maher Gandhi has been awarded $3.6 million to improve treatment for relapsed lymphoma patients.

18

Feb

$3.6 million awarded to develop treatment for relapsed lymphoma patients

Dr Seth Cheetham has been awarded three grants to fund research projects addressing the role of genomic plasticity in cancer treatment.

12

Feb

Mater Researcher secures trio of funding for cancer research